SCHEMBL7804444

SCHEMBL7804444

Cc1ccc(C(=O)N2CC=C(c3cccc(OC(C)(C)C(=O)OC(C)C)c3)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 5/20 0.44
POLB P06746 1/20 0.42
ALOX15 P16050 1/20 0.42
MMP2 P08253 3/20 0.40
MMP3 P08254 3/20 0.40
PPARG P37231 2/20 0.39
PPARA Q07869 2/20 0.39
HPGD P15428 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ABCB11 O95342 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
CYP2C9 P11712 1/20 0.39
ADRB3 P13945 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7813905 0.94 ALDH1A1 (0.46) NAMPTPOLBALOX15PPARGPPARA
SCHEMBL7809885 0.93 POLB (0.41) NAMPTPOLBALOX15MMP2MMP3
SCHEMBL7811486 0.93 PPARG (0.49) NAMPTPOLBALOX15MMP2MMP3
SCHEMBL7817528 0.93 NAMPT (0.49) NAMPTPOLBALOX15MMP2MMP3
SCHEMBL7814015 0.93 NAMPT (0.44) NAMPTPOLBALOX15MMP2MMP3
SCHEMBL7817469 0.92 NAMPT (0.44) NAMPTPOLBALOX15MMP2MMP3
SCHEMBL7813624 0.91 POLB (0.40) NAMPTPOLBALOX15MMP2MMP3
SCHEMBL7804294 0.88 HPGD (0.39) NAMPTPOLBALOX15MMP2MMP3
SCHEMBL7813597 0.88 HPGD (0.39) NAMPTPOLBALOX15MMP2MMP3
SCHEMBL7810037 0.88 PPARG (0.50) NAMPTPOLBALOX15PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed